Cancer Gene Therapy - Table of Contents alert Volume 19 Issue 10

TABLE OF CONTENTS Volume 19, Issue 10 (October 2012) In this issue Original Articles Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement 2012 Nature/Institute for Genomic Medicine Symposium November 4-5, 2012 - La Jolla, CA, USA The following topics will be covered at the conference: Cancer Genomics, Gene & Cell Therapies, Complex Human Traits and Personalized Genomics for Implementation of Genetic Information.  Register today!   Original Articles Top A non-oncogenic HPV 16 E6/E7 vaccine enhances treatment of HPV expressing tumors B G Wieking, D W Vermeer, W C Spanos, K M Lee, P Vermeer, W T Lee, Y Xu, E S Gabitzsch, S Balcaitis, J P Balint, Jr, F R Jones and J H Lee Cancer Gene Ther 2012 19: 667-674; advance online publication, August 24, 2012; 10.1038/cgt.2012.55 Abstract | Full Text Insertion of a nuclear factor kappa B DNA nuclear-targeting sequence potentiates suicide gene therapy efficacy in lung cancer cell lines F Cramer, C L Christensen, T T Poulsen, M A Badding, D A Dean and H S Poulsen Cancer Gene Ther 2012 19: 675-683; advance online publication, August 17, 2012; 10.1038/cgt.2012.54 Abstract | Full Text Knockdown of zinc finger protein X-linked inhibits prostate cancer cell proliferation and induces apoptosis by activating caspase-3 and caspase-9 H Jiang, L Zhang, J Liu, Z Chen, R Na, G Ding, H Zhang and Q Ding Cancer Gene Ther 2012 19: 684-689; advance online publication, August 17, 2012; 10.1038/cgt.2012.53 Abstract | Full Text Human positive coactivator 4 is a potential novel therapeutic target in non-small cell lung cancer Y Peng, J Yang, E Zhang, H Sun, Q Wang, T Wang, Y Su and C Shi Cancer Gene Ther 2012 19: 690-696; advance online publication, August 24, 2012; 10.1038/cgt.2012.52 Abstract | Full Text Enhanced radiosensitivity of non-small-cell lung cancer (NSCLC) by adenovirus-mediated ING4 gene therapy C Ling, Y Xie, D Zhao, Y Zhu, J Xiang and J Yang Cancer Gene Ther 2012 19: 697-706; advance online publication, August 3, 2012; 10.1038/cgt.2012.50 Abstract | Full Text Treatment of breast cancer stem cells with oncolytic herpes simplex virus J Li, W Zeng, Y Huang, Q Zhang, P Hu, S D Rabkin and R Liu Cancer Gene Ther 2012 19: 707-714; advance online publication, August 17, 2012; 10.1038/cgt.2012.49 Abstract | Full Text Effect of silencing PARG in human colon carcinoma LoVo cells on the ability of HUVEC migration and proliferation J Pan, N J S Fauzee, Y-l Wang, Y-T Sheng, Y Tang, J-Q Wang, W-q Wu, J-x Yan and J Xu Cancer Gene Ther 2012 19: 715-722; advance online publication, August 24, 2012; 10.1038/cgt.2012.48 Abstract | Full Text Advertisement SPECIAL FOCUS The great strides in advancing resolution in genetic diagnosis, largely due to molecular techniques with nextgen sequencing as trailblazer, is fuelling the debate on the discordance between resolution and precision. Somewhere between those two lies the holy grail of patient benefit. Do we need to find everything, and can we, already? Follow the debate on the EJHG web focus on Psychosocial aspects of advancing genetics   Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Cancer Gene Therapy. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2012 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.